Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

HK public hospital experience: Earlier use of 2L therapies improves maternal outcomes, despite rise in massive primary PPH
29 Aug 2026
bởiNatalia Reoutova
A study conducted at a single public maternity unit in Hong Kong reports a 67 percent increase in massive primary postpartum haemorrhage (PPH) between 2006–2011 and 2017–2022, as well as considerable improvements in maternal outcomes, such as lower blood loss and hysterectomy rate, owing to increased use of second-line (2L) therapies.
29 Aug 2026

10 years after CAR T-cell therapy: 32–47 percent OS in R/R B-cell NHL
29 Aug 2026
bởiNatalia Reoutova
A phase II study of patients with heavily pretreated B-cell non-Hodgkin lymphoma (NHL) reports decade-long remissions in approximately one-third of patients with large B-cell lymphomas (LBCL) and in nearly half of patients with follicular lymphoma (FL), following a single infusion of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, tisagenlecleucel.
29 Aug 2026






